Metoclopramide
- Product NDC
- 0703-4502
- 11-digit product format
- 007034502
- Labeler code
- 0703
- Product ID
- 0703-4502_e640a87c-7ee3-4ca2-9808-3916bfd1a54b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metoclopramide
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Teva Parenteral Medicines, Inc.
- Application
- ANDA073135
- Marketing category
- ANDA
- Marketing start
- 1991-12-01
- Substance
- METOCLOPRAMIDE HYDROCHLORIDE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Metoclopramide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METOCLOPRAMIDE HYDROCHLORIDE | 5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | W1792A2RVD |
| Rxcui | 311670 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0703-4502-01 | Metoclopramide | 2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 2 | | 14 |
| 0703-4502-04 | Metoclopramide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 14 |
| 0703-4502-91 | Metoclopramide | 2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 2 | | 8 |
| 0703-4502-93 | Metoclopramide | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | | 8 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| METOCLOPRAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | W1792A2RVD | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 8 | |
| METOCLOPRAMIDE | ACTIVE MOIETY | L4YEB44I46 | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 8 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 8 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 8 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 8 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 8 | |
| METOCLOPRAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | W1792A2RVD | METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] | 3 | |
| METOCLOPRAMIDE | ACTIVE MOIETY | L4YEB44I46 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] | 3 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] | 3 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] | 3 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] | 3 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH] | 3 | |
| METOCLOPRAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | W1792A2RVD | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 1 | |
| METOCLOPRAMIDE | ACTIVE MOIETY | L4YEB44I46 | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0703-4502 | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 13 | Current NDC, Legacy NDC, 2 package rows | 20230628_cccf04bd-7463-40b8-a41f-cb1093c358d7.zip |
| 0703-4502 | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | Current NDC, Legacy NDC, 2 package rows | 20240906_5645a752-8868-4b51-8b59-48bb4276d763.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0703-4502-01 | 00703450201 | 2 mL in 1 VIAL, SINGLE-USE | 2 ml | | | | | Historical |
| 0703-4502-04 | 00703450204 | 25 VIAL, SINGLE-USE in 1 TRAY (0703-4502-04) / 2 mL in 1 VIAL, SINGLE-USE (0703-4502-01) | | 1991-12-01 | 0000-00-00 | No | No | Current |
| 0703-4502-84 | 00703450284 | 25 VIAL, SINGLE-USE in 1 TRAY (0703-4502-84) > 2 mL in 1 VIAL, SINGLE-USE (0703-4502-81) | | 2015-08-17 | 2021-03-31 | No | No | Current |
| 0703-4502-91 | 00703450291 | 2 mL in 1 VIAL, SINGLE-USE | 2 ml | | | | | Historical |
| 0703-4502-93 | 00703450293 | 10 VIAL, SINGLE-USE in 1 CARTON (0703-4502-93) / 2 mL in 1 VIAL, SINGLE-USE (0703-4502-91) | | 2024-09-04 | | No | No | Historical |